Turka Laurence A.'s Form 4 filing
Rubius Therapeutics, Inc. (RUBY) · filed Jan 31, 2023
- Accession no.
- 0001104659-23-008873
- Filed
- Jan 31, 2023, 9:50 PM ET
- Trade date
- Jan 29-31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $622.32. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Turka Laurence A.CIK 0001800952 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2023 | Common Stock | MOption exerciseAcquired | +7,438 | –F1 | – | 12,359 | Direct | |
| Jan 31, 2023 | Common Stock | MOption exerciseAcquired | +8,625 | –F1 | – | 20,984 | Direct | |
| Jan 31, 2023 | Common Stock | SSaleDisposed | −2,593 | $0.24 | −$622.32 | 18,391 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2023 | Common Stock | MOption exerciseDisposed | −7,438 | $0.00 | $0 | 14,874 | Direct | |
| Jan 31, 2023 | Common Stock | MOption exerciseDisposed | −8,625 | $0.00 | $0 | 25,875 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Referenced by the price of 2 transactions in Table I.
Remarks
Exhibit List - Exhibit 24 - Power of Attorney